Stereoselective Synthesis of 2-Aminocyclobutanols
A R T I C L E S
column chromatography (silica gel, PE/EE 4:1) to give 4a in 34%.
2-Benzoyl-3-methyl-pentanoic acid ethyl ester (4b) was synthesized
likewise in 41% yield (Table 4).
N-(2-Hydroxy-3,4-dimethyl-2-p-tolyl-cyclobutyl)-acetamide (2g).
79%, mp 204-205 °C. H NMR (CDCl3, 300 MHz): δ 1.18 (d, 3H,
1
J 6.1), 1.19 (d, 3H, J 6.1), 1.89 (m, 1H), 2.03 (s, 3H), 2.02-2.05 (m,
1H), 2.37 (s, 3H), 4.19 (d, 1H, J 8.8), 6.32 (d, 1H, J 8.8), 7.18 (d, 2H,
J 7.9), 7.34 (d, 2H, J 7.9). 13C NMR (CDCl3, 75.5 MHz): δ 12.1 (CH3),
18.0 (CH3), 21.4 (CH3), 23.0 (CH3), 43.1 (CH), 44.8 (CH), 57.7 (CH),
80.6 (Cq), 126.6 (CH), 130.1 (CH), 138.0 (Cq), 144.4 (Cq), 173.1 (Cq).
Anal. Calcd for C15H21NO2 (247.3): C, 72.84; H, 8.56; N, 5.66.
Found: C, 72.99; H, 8.40; N, 5.47.
Photolyses of 1a-1l and 4a,b. General Procedure. A solution of
0.2 mmol of the starting material in 50 mL of benzene was irradiated
under a nitrogen atmosphere at 15 °C for 5 h (TLC- and GC-control)
with phosphor-coated mercury low-pressure lamps emitting at 350 (
20 nm. After evaporation of the solvent, the crude reaction mixture
was separated and purified by column chromatography (silica gel, PE/
EE 2:1). The Norrish I cleavage products are all literature-known and
were compared with authentic samples or spectral data from the
literature. As a Norrish II cleavage product, N-(4-methyl-benzoyl)-
acetamide (3) was formed during the photolyses of 1a-1g, and the
corresponding amides were formed from 1h-1l.
N-(2-Hydroxy-3-methyl-2-p-tolyl-cyclobutyl)-acetamide (2b). 22%,
colorless oil. 1H NMR (CDCl3, 300 MHz): δ 1.11 (d, 3H, J 6.6), 1.66
(m, 1H), 1.91 (s, 3H), 2.29 (s, 3H), 2.30 (m, 1H), 2.39 (m, 1H), 4.95
(m, 1H), 6.47 (d, 1H, J 8.6), 7.09 (d, 2H, J 7.9), 7.24 (d, 2H, J 7.9).
13C NMR (CDCl3, 75.5 MHz): δ 12.6 (CH3), 20.9 (CH3), 23.1 (CH3),
35.0 (CH), 39.3 (CH2), 55.7 (CH), 74.0 (Cq), 81.4 (Cq), 124.9 (CH),
129.2 (CH), 137.3 (Cq), 141.9 (Cq), 169.7 (Cq). Anal. Calcd for C14H19-
NO2 (233.3): C, 72.07; H, 8.21; N, 6.00. Found: C, 71.83; H, 8.16;
N, 5.75.
N-(2-Hydroxy-3-ethyl-2-p-tolyl-cyclobutyl)-acetamide (2c). 41%,
colorless oil. 1H NMR (CDCl3, 300 MHz): δ 0.82 (t, 3H, J 7.3), 1.60
(m, 1H), 1.91 (s, 3H), 2.21 (m, 1H), 2.29 (s, 3H), 2.41 (m, 1H), 4.56
(m, 1H), 6.49 (d, 1H, J 8.8), 7.09 (d, 2H, J 7.9), 7.28 (d, 2H, J 7.9).
13C NMR (CDCl3, 75.5 MHz): δ 11.5 (CH3), 21.0 (CH2), 21.3 (CH3),
23.2 (CH3), 32.4 (CH2), 42.1 (CH), 48.4 (CH), 81.4 (Cq), 124.8 (CH),
129.1 (CH), 137.1 (CH), 141.7 (Cq), 169.7 (Cq). Anal. Calcd for C15H21-
NO2 (247.3): C, 72.84; H, 8.56; N, 5.66. Found: C, 71.72; H, 8.46;
N, 5.56.
N-(2-Hydroxy-4-methyl-2-p-tolyl-cyclobutyl)-benzamide (2h). ca.
1
65% (from crude NMR), colorless oil. H NMR (CDCl3, 300 MHz):
δ 1.14 (d, 3H, J 6.8), 1.78 (dd, 1H, 1H, J 9.8, 11.9), 2.32 (s, 3H), 2.31
(m, 2H), 4.49 (t, 1H, J 8.8), 7.02-7.85 (m, 9H).
1-(2-Hydroxy-4-methyl-2-p-tolyl-cyclobutyl)-pyrrolidine-2,5-di-
1
one (2i). ca. 65% (from crude NMR). H NMR (CDCl3, 300 MHz) δ
1.15 (d, 3H, J 6.6), 1.96 (dd, 1H, J 9.2, 12.3), 2.30 (s, 3H), 2.57 (dd,
1H, J 12.3), 2.74 (s, 4H), 2.78 (m, 1H), 4.58 (d, 1H, J 9.4), 7.11 (d,
2H, J 7.9), 7.29 (d, 2H, J 7.9). 13C NMR (CDCl3, 75.5 MHz): δ 19.6
(CH3), 20.9 (CH3), 27.8 (CH2), 41.7 (CH2), 44.6 (CH), 60.7 (Cq), 80.5
(Cq), 124.8 (CH), 129.1 (CH), 136.9 (Cq), 141.1 (Cq), 179.2 (Cq).
1-(6-Hydroxy-6-phenyl-5-aza-bicyclo[2.1.1]hex-5-yl)-ethanone (2l).
1H NMR (CDCl3, 300 MHz, mixture with N-acetylpyrrolidine): δ 1.88
(m, 4H), 2.00 (s, 3H), 2.31 (s, 3H), 5.22 (m, 2H), 7.14 (d, 2H, J 7.9),
7.28 (d, 2H, J 7.9). 13C NMR (CDCl3, 75.5 MHz, mixture with
N-acetylpyrrolidine): δ 20.6 (CH3), 22.1 (CH2), 24.3 (CH3), 63.0 (CH),
77.2 (Cq), 125.4 (CH), 129.2 (CH), 137.6 (Cq), 144.0 (Cq), 169.1 (Cq).
N-(4-Methyl-benzoyl)-acetamide (3). mp 142 °C (143 °C).51
Ethyl 2-Hydroxy-4-methyl-2-phenyl-cyclobutanoate (5a). ca. 26%
1
(from crude NMR, mixture with the Norrish I cleavage product). H
NMR (CDCl3, 300 MHz): δ 1.21 (d, 3H, J 6.9), 1.22 (t, 3H, J 6.8),
1.99 (dd, 1H, J 9.1, 13.1), 2.48 (dd, 1H, J 8.2, 13.1), 2.92 (m, 1H),
3.21 (d, 1H, J 9.2), 4.21 (q, 2H, J 6.8), 7.23-7.49 (m, 5H). 13C NMR
(CDCl3, 75.5 MHz): δ 14.2 (CH3), 20.6 (CH3), 29.4 (CH), 41.3 (CH2),
54.1 (CH), 75.6 (Cq), 124.9 (CH), 127.3 (CH), 128.2 (CH), 146.1 (Cq),
173.2 (Cq).
N-(2-Hydroxy-3,3-dimethyl-2-p-tolyl-cyclobutyl)-acetamide (2d).
1
47%, mp 192-194 °C. H NMR (CDCl3, 300 MHz): δ 0.76 (s, 3H),
1.21 (s, 3H), 1.83 (m, 1H), 1.90 (s, 3H), 2.02 (m, 1H), 2.28 (s, 3H),
5.06 (m, 1H), 6.45 (d, 1H, J 8.3), 7.07 (d, 2H, J 7.9), 7.21 (d, 2H, J
7.9). 13C NMR (CDCl3, 75.5 MHz): δ 21.1 (CH3), 21.2 (CH3), 21.7
(CH3), 23.4 (CH3), 38.9 (CH2), 42.6 (Cq), 52.6 (CH), 77.3 (Cq), 124.9
(CH), 129.1 (CH), 137.4 (Cq), 141.7 (Cq), 169.7 (Cq). Anal. Calcd for
C15H21NO2 (247.3): C, 72.84; H, 8.56; N, 5.66. Found: C, 72.16; H,
8.49; N, 5.98.
N-(2-Hydroxy-4-methyl-2-p-tolyl-cyclobutyl)-acetamide (2e). 52%,
mp 172-173 °C. 1H NMR (CDCl3, 300 MHz): δ 1.19 (d, 3H, J 6.6),
1.78 (dd, 1H, J 9.7, 11.8), 2.02 (s, 3H), 2.31 (s, 3H), 2.38 (m, 2H),
4.36 (t, 3H, J 8.9), 6.30 (d, 1H, J 8.4), 7.14 (d, 2H, J 7.9), 7.28 (d, 2H,
J 7.9). 13C NMR (CDCl3, 75.5 MHz): δ 19.1 (CH3), 21.0 (CH3), 23.4
(CH3), 35.2 (CH), 38.5 (CH2), 56.9 (CH), 78.0 (Cq), 124.9 (CH), 129.1
(CH), 137.4 (Cq), 141.8 (Cq), 169.6 (Cq). Anal. Calcd for C14H19NO2
(233.3): C, 72.07; H, 8.21; N, 6.00. Found: C, 71.09; H, 8.16; N,
5.79.
N-(2-Hydroxy-4,4-dimethyl-2-p-tolyl-cyclobutyl)-acetamide (2f).
43%, colorless oil. 1H NMR (CDCl3, 300 MHz): δ 1.19 (s, 3H), 1.21
(s, 3H), 2.01 (s, 3H), 2.06 (d, 1H, J 9.5), 2.33 (s, 3H), 3.04 (d, 1H, J
9.5), 4.49 (d, 1H, J 9.0), 6.22 (d, 1H, J 9.0), 7.15 (d, 2H, J 7.9), 7.25
(d, 2H, J 7.9). 13C NMR (CDCl3, 75.5 MHz): δ 21.0 (CH3), 23.3 (CH3),
23.4 (CH3), 29.8 (CH3), 36.6 (CH2), 38.1 (Cq), 58.1 (CH), 75.9 (Cq),
124.8 (CH), 129.1 (CH), 130.1 (Cq), 137.2 (Cq), 169.9 (CHq). Anal.
Calcd for C15H21NO2 (247.3): C, 72.84; H, 8.56; N, 5.66. Found: C,
72.34; H, 8.34; N, 5.39.
Ethyl 2-Hydroxy-3,4-dimethyl-2-phenyl-cyclobutanoate (5b). ca.
15% (from crude NMR, mixture with the Norrish I cleavage product).
1. diastereoisomer, 1H NMR (CDCl3, 300 MHz): δ 0.55 (d, 3H, J 7.7),
1.01 (d, 3H, J 6.8), 1.22 (t, 3H, J 6.8), 2.45 (m, 1H), 3.02 (m, 1H),
3.20 (d, 1H, J 10.1), 4.21 (q, 2H, J 6.8), 7.23-7.49 (m, 5H). 2.
1
diastereoisomer, H NMR (CDCl3, 300 MHz): δ 1.06 (d, 3H, J 6.8),
1.12 (d, 3H, J 6.8), 1.22 (t, 3H, J 6.8), 2.05 (m, 1H), 2.34 (m, 1H),
2.81 (d, 1H, J 9.4), 4.23 (q, 2H, J 6.8), 7.23-7.49 (m, 5H).
Acknowledgment. Financial support by the Deutsche Fors-
chungsgemeinschaft (GR-881/7-1,2,3) and the Fonds der Chem-
ischen Industrie is greatly acknowledged. For generous gifts of
amino acids we thank the Degussa AG. We are grateful to
Andrei Kutateladze for informing us about his work on the
conformational dependence of SOC in 2-oxatetramethylenes.44
JA0111941
(51) Knittel, D. Monatsh. Chem. 1986, 117, 679-688.
(52) Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.;
Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem.
1990, 11, 440-467.
9
J. AM. CHEM. SOC. VOL. 124, NO. 3, 2002 403